I. Overview
The park covers a planned area of 15.12 square kilometers and consists of the Modern Commerce District and the Western Smart Medical Trade Industrial Park District, forming an economic and geographical layout of “One Core, Three Parks, and One Axis.”The “One Core” refers to the Liaojiawan area within the former Chengbei New Consumer Vitality Zone as the core region; the “Three Parks” refer to the three major Smart Medical and Trade Industrial Park zones in Dafeng, Xinfan, and Shibantan; and the “One Axis” refers to Rongdu Avenue as the development axis, which connects high-quality commercial resources from north to south, including Yinma River, Qiyi Suning, Hexin Center, Jinmen, Wulongshan Auto Town, and Feiteng Town.

II. Development Goals

Guided by the principles of “project-driven development, brand aggregation, functional integration, and differentiated development,” and oriented toward the high-quality development of industrial parks, the strategy centers on the flow of people and goods. It focuses on the modern commerce and trade industrial system, accelerates the establishment of two distinctive strengths—commerce services and smart medical trade—and gradually expands into niche sectors such as specialty cuisine, intangible cultural heritage and cultural creativity,sports and fitness, and automotive exhibitions and trade. We will accelerate the implementation of the “One Axis, One Corridor, Multiple Clusters” spatial layout. Through brand building, enterprise recruitment, scenario creation, and platform development, we will drive the upgrading of the modern commerce and trade industrial cluster to achieve “full resources, full benefits, and full vitality,” transforming the park into the northern metropolitan area’s “Demonstration Zone for the Integration of Culture, Sports, Tourism, and Beauty” and the “International Medical Supply Chain Demonstration Zone.”

III. Industrial Development Status

The park currently hosts 126 enterprises meeting or exceeding scale requirements, with a total revenue of 53 billion yuan in 2023. It has been successively recognized as a Sichuan Provincial Modern Service Industry Cluster and a Provincial Pilot Zone for the Innovative Development of Sichuan-Style Cuisine. Within the park, the Boiling Town has been designated a Sichuan Provincial Characteristic Town, and the park features three municipal-level consumer experience zones.

Focusing on the two key sectors of modern commerce and smart medical trade, the park is home to six flagship enterprises: Chengdu Yuntu Holding Co., Ltd., China Resources Kelun Pharmaceutical (Sichuan) Co., Ltd., Jiangyao Group (Sichuan) Co., Ltd., Sinopharm Holding (Chengdu) Co., Ltd., Chengdu JD Nanyuan Trading Co., Ltd., and Yumi Coco Network Technology Co., Ltd.

Chengdu Yuntu Holding Co., Ltd.: With annual revenue exceeding 10 billion yuan, the company was selected for the Ministry of Industry and Information Technology’s third batch of demonstration enterprises for service-oriented manufacturing. It has participated in drafting one international standard, four industry standards, and seven group standards, all of which have been promulgated and implemented. Ranked third in the “fertilizer industry” on the A-share market, it is a leading enterprise in China’s compound fertilizer sector.

China Resources Kelun Pharmaceutical (Sichuan) Co., Ltd.: Established on September 19, 2023, through a joint investment by China Resources Pharmaceutical Commercial Group and Kelun Group, it is a large state-owned pharmaceutical distribution enterprise controlled by China Resources Pharmaceutical Commercial Group in the Southwest region. It also serves as the Group’s primary management platform in the Southwest—China Resources Pharmaceutical Commercial Southwest Region, abbreviated as China Resources Kelun (Southwest Region).China Resources Kelun (Southwest Region) oversees four provinces and one municipality—Sichuan, Jiangxi, Yunnan, Chongqing, and Guizhou—and operates 24 pharmaceutical distribution companies. With a sales volume of 16 billion yuan in 2023, it is a leading pharmaceutical distribution enterprise in the Southwest region, integrating pharmaceutical wholesale, hospital sales, and medical device distribution.It primarily deals in Chinese and Western medicines, medical devices, biological products, traditional Chinese herbal decoctions, and health supplements, with a product portfolio of 40,000 SKUs. Leveraging the Group’s strengths, CR Pharmaceutical (Southwest Region) has established strong and stable partnerships with globally renowned pharmaceutical manufacturers, pharmaceutical distribution companies, and medical institutions.The company’s smart logistics center, built in Shiban Tan Subdistrict, Xindu District, Chengdu, features nearly 80,000 square meters of cool storage and 3,000 square meters of refrigerated and frozen storage. It is equipped with intelligent, digitized, and automated pallet racking, container racking, picking systems, and storage and transportation management systems, capable of handling 60,000 SKUs for unit-picking, storing 830,000 items, and processing an average of 120,000 items in daily inbound and outbound operations.Additionally, the company maintains a comprehensive province-wide distribution network for pharmaceuticals and medical devices in Sichuan, as well as a direct cold-chain pharmaceutical delivery system, laying a solid foundation for efficient, rapid, and reliable services in vaccine distribution across Sichuan and third-party logistics operations.

Jiangya Group (Sichuan) Co., Ltd.: As a provincial-level platform company under Jiangya Group Co., Ltd., it serves as the largest pure-end-user pharmaceutical distribution platform in Southwest China within the Jiangya Group. Established in December 2018 with a registered capital of 7.5 billion yuan, Jiangya Group is a state-controlled mixed-ownership enterprise established by Jiangxi Provincial State-owned Capital Operation Holding Group Co., Ltd.Jiangyao Sichuan is located in Xindu District, Chengdu City, Sichuan Province—known as the “Land of Abundance”—and employs over 400 staff members, including a marketing team of more than 130. With over a decade of experience in pharmaceutical sales and medical device distribution, it is a medium-to-large-scale, state-owned mixed-ownership pharmaceutical enterprise characterized by highly modern management standards.

Sinopharm Holding Chengdu Pharmaceutical Co., Ltd.: Established in 2006, it is one of the subsidiaries of China National Pharmaceutical Group in Sichuan (a central state-owned enterprise subsidiary in Sichuan) and a modern pharmaceutical distribution enterprise specializing in the wholesale of pharmaceuticals and medical devices, wholly owned by Sinopharm Holding Sichuan Pharmaceutical Co., Ltd. The company has a registered capital of 30 million yuan and operates one comprehensive smart community pharmacy.Since its establishment, the company has maintained steady growth with an average annual growth rate in the double digits. In 2023, its sales (including tax) exceeded 2.9 billion yuan. From 2006 to 2023, the company paid a cumulative total of 157.9 million yuan in taxes and fees, received the Chengdu Xindu District Advanced Taxpayer Award for five consecutive years, and was awarded the "Five Consecutive A-Rated" tax credit rating for the 2018–2022 period.The company currently works with nearly 2,000 suppliers and offers over 20,000 product varieties, having established strong partnerships with the top 20 global pharmaceutical companies and China’s top 100 pharmaceutical enterprises. Centered in Chengdu, the company has built a channel network that extends across the province and reaches deep into grassroots communities, covering more than 95% of the province’s retail chains, standalone pharmacies near hospitals, and municipal and county-level commercial companies.

Chengdu JD Nanyuan Trading Co., Ltd.: Located in the JD Asia No. 1 Chengdu Xindu Logistics Park, 20 kilometers from downtown Chengdu, the facility complements JD’s Asia No. 1 site in Chengdu’s Tianfu New Area to form a north-south operational layout. The project currently boasts a storage capacity of 2 million SKUs and a sorting center capable of processing over 1.2 million items per day. Its business scope extends across the entire Southwest region, making it a critical operational hub for JD in the Southwest.The project employs advanced smart logistics equipment, including an automated high-density storage system (AS/RS) with aisle stackers, a high-speed automated sorting system, and an automatic merging system for small-item conveyor lines. These enhancements have boosted the production efficiency of the logistics infrastructure, enabling an annual order processing capacity of over 100 million orders and significantly driving the development of e-commerce logistics infrastructure across the entire Southwest region.Benefiting from the trade-in policy, JD Nanyuan saw continued growth in 2024, achieving revenue of 3.704 billion yuan from January to November, a year-over-year increase of 34.6%.

Yumi Coco Network Technology Co., Ltd.: Yumi Coco Network Technology is a company centered on brand operations. Its flagship brand, Qizuo, is China’s first fully disassembled and washable mattress brand and currently the only high-end mattress series in the domestic market launched as a Chinese national brand. Yumi Coco’s operations revolve around the brand, encompassing product R&D, social media, data management, new retail, and user engagement, positioning it as a platform-based consumer brand enterprise.The company operates its own flagship e-commerce stores across all online platforms and maintains physical experience stores in over 50 cities nationwide. Since its establishment in March 2019, the company has successively established an Operations Center, a Social Media Department, a New Retail Center, a Short Video Center (in Chenghua District), a Live Streaming Center, and a R&D and Production Base. Nationwide, there are 593 non-production staff members (of which approximately 300 are based at the Dafeng headquarters);and 172 production staff; the 2023 output value is approximately 450 million yuan. Excluding production line workers, the average age of the team is under 27, with approximately 4.5% holding master’s degrees, 70.5% holding bachelor’s degrees, and 25% holding associate degrees.